World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
64
Citations
24065
World Ranking
2888
National Ranking
1362

Paulo C. Rodriguez publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Paulo C. Rodriguez sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 292 publications — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Paulo C. Rodriguez D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Paulo C. Rodriguez sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 64 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Paulo C. Rodriguez is affiliated with the Moffitt Cancer Center in the United States. Their research spans a range of topics primarily within medicine, immunology and microbiology, and biochemistry, genetics and molecular biology. The scientist's work focuses heavily on immunology, oncology, molecular biology, cancer research, and epidemiology.

The main topics covered in their research include:

  • Cancer Immunotherapy and Biomarkers
  • Immune Cell Function and Interaction
  • CAR-T cell therapy research
  • Immunotherapy and Immune Responses
  • Immune cells in cancer
  • Phagocytosis and Immune Regulation
  • T-cell and B-cell Immunology

Among their recent notable papers are:

  • Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma, 2021, Blood
  • IgA transcytosis and antigen recognition govern ovarian cancer immunity, 2021, Nature
  • The inhibitory receptor TIM-3 limits activation of the cGAS-STING pathway in intra-tumoral dendritic cells by suppressing extracellular DNA uptake, 2021, Immunity
  • The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling, 2020, Immunity
  • CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint, 2020, Nature Communications

Frequent coauthors collaborating with this scientist include:

  • José R. Conejo-García
  • Xiaoqing Yu
  • Xuefeng Wang
  • Keiran S.M. Smalley
  • Jay K. Mandula

Their work is regularly published in notable venues, with multiple publications in:

  • Cancer Research
  • The Journal of Immunology
  • Immunity
  • Cancer Cell
  • Regular and Young Investigator Award Abstracts

Paulo C. Rodriguez has contributed to over one hundred scientific publications predominantly in medicine, with 91 publications in immunology and microbiology and 50 within biochemistry, genetics, and molecular biology. The scientist's research broadly addresses cancer immunotherapy approaches, immune mechanisms in the tumor microenvironment, and the molecular interactions driving immune regulation and cancer progression.

Best Publications

  • Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

    Vincenzo Bronte;Sven Brandau;Shu Hsia Chen;Mario P. Colombo

  • Arginase I Production in the Tumor Microenvironment by Mature Myeloid Cells Inhibits T-Cell Receptor Expression and Antigen-Specific T-Cell Responses

    Paulo C. Rodriguez;David G. Quiceno;Jovanny Zabaleta;Blair Ortiz

  • Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine.

    Minu K. Srivastava;Pratima Sinha;Virginia K. Clements;Paulo Rodriguez

  • l-arginine availability regulates T-lymphocyte cell-cycle progression

    Paulo C. Rodriguez;David G. Quiceno;Augusto C. Ochoa

  • Arginase-Producing Myeloid Suppressor Cells in Renal Cell Carcinoma Patients: A Mechanism of Tumor Evasion

    Arnold H. Zea;Paulo C. Rodriguez;Michael B. Atkins;Claudia Hernandez

  • B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma

    Ilona Kryczek;Ilona Kryczek;Linhua Zou;Linhua Zou;Paulo Rodriguez;Gefeng Zhu

  • Arginase I–Producing Myeloid-Derived Suppressor Cells in Renal Cell Carcinoma Are a Subpopulation of Activated Granulocytes

    Paulo C. Rodriguez;Marc S. Ernstoff;Claudia Hernandez;Michael Atkins

  • Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives.

    Paulo C. Rodríguez;Augusto C. Ochoa

  • Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma.

    Paulo C Rodriguez;Claudia P. Hernandez;David G. Quiceno;Steven M Dubinett

  • Arginase, Prostaglandins, and Myeloid-Derived Suppressor Cells in Renal Cell Carcinoma

    Augusto C. Ochoa;Arnold H. Zea;Claudia Hernandez;Paulo C. Rodriguez

  • l-Arginine Consumption by Macrophages Modulates the Expression of CD3ζ Chain in T Lymphocytes

    Paulo C. Rodriguez;Arnold H. Zea;Joanna DeSalvo;Kirk S. Culotta

  • Regulation of T Cell Receptor CD3ζ Chain Expression byl-Arginine

    Paulo C. Rodriguez;Arnold H. Zea;Kirk S. Culotta;Jovanny Zabaleta

  • Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies

    Fokhrul Hossain;Amir A. Al-Khami;Dorota Wyczechowska;Claudia Hernandez

  • Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13.

    Steven L. Highfill;Paulo C. Rodriguez;Qing Zhou;Christine A. Goetz

  • IRE1α–XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity

    Minkyung Song;Tito A. Sandoval;Chang-Suk Chae;Sahil Chopra

  • Metabolism of L-arginine by myeloid-derived suppressor cells in cancer: mechanisms of T cell suppression and therapeutic perspectives.

    Patrick Raber;Augusto C Ochoa;Paulo C Rodríguez

  • Tumor-Infiltrating Regulatory Dendritic Cells Inhibit CD8+ T Cell Function via l-Arginine Metabolism

    Lyse A. Norian;Paulo C. Rodriguez;Leigh A. O'Mara;Jovanny Zabaleta

  • Exogenous lipid uptake induces metabolic and functional reprogramming of tumor-associated myeloid-derived suppressor cells

    Amir A. Al-Khami;Liqin Zheng;Luis Del Valle;Fokhrul Hossain

  • Subpopulations of myeloid-derived suppressor cells impair T cell responses through independent nitric oxide-related pathways

    Patrick L. Raber;Paul Thevenot;Rosa Sierra;Dorota Wyczechowska

  • Arginine Metabolism in Myeloid Cells Shapes Innate and Adaptive Immunity.

    Paulo C. Rodriguez;Augusto C. Ochoa;Amir A. Al-Khami

  • l-Arginine modulates CD3ζ expression and T cell function in activated human T lymphocytes

    Arnold H. Zea;Paulo C. Rodriguez;Kirk S. Culotta;Claudia P. Hernandez

  • The Stress-Response Sensor Chop Regulates the Function and Accumulation of Myeloid-Derived Suppressor Cells in Tumors

    Paul T. Thevenot;Rosa A. Sierra;Patrick L. Raber;Amir A. Al-Khami

Frequent Co-Authors

Jose R. Conejo-Garcia
Jose R. Conejo-Garcia Duke University
David H. Munn
David H. Munn Augusta University
Luis Del Valle
Luis Del Valle Louisiana State University Health Sciences Center New Orleans
Barbara A. Osborne
Barbara A. Osborne University of Massachusetts Amherst
Ali S. Arbab
Ali S. Arbab Augusta University
Lucio Miele
Lucio Miele Louisiana State University Health Sciences Center New Orleans
Bruce R. Blazar
Bruce R. Blazar University of Minnesota
Weiping Zou
Weiping Zou University of Michigan–Ann Arbor
Krzysztof Reiss
Krzysztof Reiss Louisiana State University Health Sciences Center New Orleans
Walter J. Lukiw
Walter J. Lukiw Louisiana State University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, related healthcare fields like nursing offer many online educational opportunities. Accelerated programs provide a faster path to entering the nursing profession, especially for individuals transitioning from other careers. Exploring an online accelerated nursing programs for non nurses can be a practical step for those seeking to complement their immunology background with clinical skills.

Among these options, some institutions offer the easiest absn program to get into, making it accessible for candidates who want to pursue a Bachelor of Science in Nursing quickly. Similarly, practical nursing offers entry points for healthcare careers through easiest lpn programs to get into. These programs provide foundational knowledge that supports the broader understanding required in immunology-related roles.

For advancement, many choose to specialize further by enrolling in easy nurse practitioner programs to get into. These degrees enable practitioners to work closely with patients, applying immunological concepts in clinical settings. Overall, combining immunology with nursing careers enhances professional versatility and opens a range of healthcare opportunities.

Best Scientists Citing Paulo C. Rodriguez

Trending Scientists

Recently Published Articles